Issues for Conceptual Design of AFCF and CFTC LWR Spent Fuel Separations Influencing Next-Generation Aqueous Fuel Reprocessing

In 2007, the U.S. Department of Energy (DOE) published the Global Nuclear Energy Partnership (GNEP) strategic plan, which aims to meet US and international energy, safeguards, fuel supply and environmental needs by harnessing national laboratory R&D, deployment by industry and use of international partnerships. Initially, two industry-led commercial scale facilities, an advanced burner reactor (ABR) and a consolidated fuel treatment center (CFTC), and one developmental facility, an advanced fuel cycle facility (AFCF) are proposed. The national laboratories will lead the AFCF to provide an internationally recognized R&D center of excellence for developing transmutation fuels and targets and advancing fuel cycle reprocessing technology using aqueous and pyrochemical methods. The design drivers for AFCF and the CFTC LWR spent fuel separations are expected to impact on and partly reflect those for industry, which is engaging with DOE in studies for CFTC and ABR through the recent GNEP funding opportunity announcement (FOA). The paper summarizes the state-of-the-art of aqueous reprocessing, gives an assessment of engineering drivers for U.S. aqueous processing facilities, examines historic plant capital costs and provides conclusions with a view to influencing design of next-generation fuel reprocessing plants

Sea-level rise will likely accelerate rock coast cliff retreat rates

Coastal response to anthropogenic climate change is of central importance to the infrastructure and inhabitants in these areas. Despite being globally ubiquitous, the stability of rock coasts has been largely neglected, and the expected acceleration of cliff erosion following sea-level rise has not been tested with empirical data, until now. We have optimised a coastal evolution model to topographic and cosmogenic radionuclide data to quantify cliff retreat rates for the past 8000 years and forecast rates for the next century. Here we show that rates of cliff retreat will increase by up to an order of magnitude by 2100 according to current predictions of sea-level rise: an increase much greater than previously predicted. This study challenges conventional coastal management practices by revealing that even historically stable rock coasts are highly sensitive to sea-level rise and should be included in future planning for global climate change response

Direct Simulation of a Solidification Benchmark Experiment

International audienceA solidification benchmark experiment is simulated using a three-dimensional cellular automaton-finite element solidification model. The experiment consists of a rectangular cavity containing a Sn-3 wt pct Pb alloy. The alloy is first melted and then solidified in the cavity. A dense array of thermocouples permits monitoring of temperatures in the cavity and in the heat exchangers surrounding the cavity. After solidification, the grain structure is revealed by metallography. X-ray radiography and inductively coupled plasma spectrometry are also conducted to access a distribution map of Pb, or macrosegregation map. The solidification model consists of solutions for heat, solute mass, and momentum conservations using the finite element method. It is coupled with a description of the development of grain structure using the cellular automaton method. A careful and direct comparison with experimental results is possible thanks to boundary conditions deduced from the temperature measurements, as well as a careful choice of the values of the material properties for simulation. Results show that the temperature maps and the macrosegregation map can only be approached with a three-dimensional simulation that includes the description of the grain structure

Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group

Objective Alcohol-related liver disease (ALD) is the most common cause of liver-related ill health and liver-related deaths in the UK, and deaths from ALD have doubled in the last decade. The management of ALD requires treatment of both liver disease and alcohol use; this necessitates effective and constructive multidisciplinary working. To support this, we have developed quality standard recommendations for the management of ALD, based on evidence and consensus expert opinion, with the aim of improving patient care. Design A multidisciplinary group of experts from the British Association for the Study of the Liver and British Society of Gastroenterology ALD Special Interest Group developed the quality standards, with input from the British Liver Trust and patient representatives. Results The standards cover three broad themes: the recognition and diagnosis of people with ALD in primary care and the liver outpatient clinic; the management of acutely decompensated ALD including acute alcoholrelated hepatitis and the posthospital care of people with advanced liver disease due to ALD. Draft quality standards were initially developed by smaller working groups and then an anonymous modified Delphi voting process was conducted by the entire group to assess the level of agreement with each statement. Statements were included when agreement was 85% or greater. Twenty-four quality standards were produced from this process which support best practice. From the final list of statements, a smaller number of auditable key performance indicators were selected to allow services to benchmark their practice and an audit tool provided. Conclusion It is hoped that services will review their practice against these recommendations and key performance indicators and institute service development where needed to improve the care of patients with ALD

A global research priority agenda to advance public health responses to fatty liver disease

Background & aims An estimated 38% of adults worldwide have non-alcoholic fatty liver disease (NAFLD). From individual impacts to widespread public health and economic consequences, the implications of this disease are profound. This study aimed to develop an aligned, prioritised fatty liver disease research agenda for the global health community. Methods Nine co-chairs drafted initial research priorities, subsequently reviewed by 40 core authors and debated during a three-day in-person meeting. Following a Delphi methodology, over two rounds, a large panel (R1 n = 344, R2 n = 288) reviewed the priorities, via Qualtrics XM, indicating agreement using a four-point Likert-scale and providing written feedback. The core group revised the draft priorities between rounds. In R2, panellists also ranked the priorities within six domains: epidemiology, models of care, treatment and care, education and awareness, patient and community perspectives, and leadership and public health policy. Results The consensus-built fatty liver disease research agenda encompasses 28 priorities. The mean percentage of ‘agree’ responses increased from 78.3 in R1 to 81.1 in R2. Five priorities received unanimous combined agreement (‘agree’ + ‘somewhat agree’); the remaining 23 priorities had >90% combined agreement. While all but one of the priorities exhibited at least a super-majority of agreement (>66.7% ‘agree’), 13 priorities had 90% combined agreement. Conclusions Adopting this multidisciplinary consensus-built research priorities agenda can deliver a step-change in addressing fatty liver disease, mitigating against its individual and societal harms and proactively altering its natural history through prevention, identification, treatment, and care. This agenda should catalyse the global health community’s efforts to advance and accelerate responses to this widespread and fast-growing public health threat. Impact and implications An estimated 38% of adults and 13% of children and adolescents worldwide have fatty liver disease, making it the most prevalent liver disease in history. Despite substantial scientific progress in the past three decades, the burden continues to grow, with an urgent need to advance understanding of how to prevent, manage, and treat the disease. Through a global consensus process, a multidisciplinary group agreed on 28 research priorities covering a broad range of themes, from disease burden, treatment, and health system responses to awareness and policy. The findings have relevance for clinical and non-clinical researchers as well as funders working on fatty liver disease and non-communicable diseases more broadly, setting out a prioritised, ranked research agenda for turning the tide on this fast-growing public health threat

Improving the Safeguardability of Nuclear Facilities

The application of a Safeguards-by-Design (SBD) process for new nuclear facilities has the potential to reduce security risks and proliferation hazards while improving the synergy of major design features and raising operational efficiency, in a world where significant expansion of nuclear energy use may occur. Correspondingly, the U.S. DOE’s Next Generation Safeguards Initiative (NGSI) includes objectives to contribute to international efforts to develop SBD, and to apply SBD in the development of new U.S. nuclear infrastructure. Here, SBD is defined as a structured approach to ensure the timely, efficient and cost effective integration of international safeguards and other nonproliferation barriers with national material control and accountability, physical protection, and safety objectives into the overall design process for a nuclear facility, from initial planning through design, construction and operation. The SBD process, in its simplest form, may be applied usefully today within most national regulatory environments. Development of a mature approach to implementing SBD requires work in the areas of requirements definition, design processes, technology and methodology, and institutionalization. The U.S. efforts described in this paper are supportive of SBD work for international safeguards that has recently been initiated by the IAEA with the participation of many stakeholders including member States, the IAEA, nuclear technology suppliers, nuclear utilities, and the broader international nonproliferation community